advanced search

Welcome: Guest

log in

Cancer Market Research

A global inventory of Cancer reports, details include Global Cancer Treatment, Vaccines, Oncology and Stakeholder Opinions.

Stay up-to-date with new products added to this category
Title Date Price
Competitor Analysis: EGF-R Agonists and Antagonists
Oct 2009 £270
Competitor Analysis: Her2 Receptor Antagonists
Sep 2009 £225
Chinese Markets for Colon Cancer Treatment Drugs
Sep 2009 £2,405
Chinese Markets for Bladder Cancer Treatment Drugs
Sep 2009 £2,405
Chinese Markets for Cervical Cancer Treatment Drugs
Sep 2009 £2,405
Chinese Markets for Brain Cancer Treatment Drugs
Sep 2009 £2,405
The German Cancer Diagnostics Market
Sep 2009 £2,465
The French Cancer Diagnostics Market
Sep 2009 £2,465
The Italian Cancer Diagnostics Market
Sep 2009 £2,465
The UK Cancer Diagnostics Market
Sep 2009 £2,465
Leading Cancer Diagnostics Market Players
Strategic Assessments of Major Suppliers and Emerging Market Entrants
Sep 2009 £1,325
Cancer Diagnostic Testing
A Global Market Overview - Facilities, Test Volumes, and Sales Forecasts by Country
Sep 2009 £390
The US Cancer Diagnostics Market
Sep 2009 £4,450
Cancer Diagnostic Technologies
Assessment of Current and Emerging Technologies, and Their Potential Market Applications
Sep 2009 £1,020
Cancer Diagnostic Testing Instrumentation
Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers
Sep 2009 £300
Cancer Diagnostics Market
New Product Development Opportunities, Market Penetration Strategies, Entry Barriers and Risks
Sep 2009 £300
Current and Emerging Cancer Diagnostic Tests
Emerging Assays and Companies Developing New Technologies and Products
Sep 2009 £1,715
The Spanish Cancer Diagnostics Market
Sep 2009 £2,465
The Japanese Cancer Diagnostics Market
Sep 2009 £3,425
Competitive Outlook on Lung Cancer Drug Development
The Missing Handbook to New Product Planning and Portfolio Planning
Aug 2009 £2,240
CHK and KSP/Eg5 Inhibitors
Competitor Analysis
Aug 2009 £155
Cancer Drug Discoveries: Colorectal Cancer
What the future holds
Jul 2009 £1,295
Bcr-Abl Kinase Inhibitors
Competitor Analysis
Jul 2009 £180
IGF-1R Antagonists
Competitor Analysis
Jul 2009 £225
HDAC Inhibitors
Competitor Analysis
Jul 2009 £355
Immunotoxins
Competitor Analysis
Jul 2009 £135
PI3K-Akt-mTOR Pathway Inhibitors
Competitor Analysis
Jul 2009 £445
Immunocytokines
Competitor Analysis
Jun 2009 £135
MEK Inhibitors
Competitor Analysis
Jun 2009 £135
Antibody-Drug Conjugates (ADC)
Competitor Analysis
Jun 2009 £225
Aurora Kinase Inhibitors
Competitor Analysis
Jun 2009 £155
Therapeutic Peptides in Oncology
Favorable Conditions But Where to Commercialize?
May 2009 £3,235
Novel Mitotic Kinase Inhibitors
Competitor Analysis
May 2009 £315
Ras-Raf-MEK-ERK Inhibitors
Competitor Analysis
May 2009 £315
Raf Inhibitors
Competitor Analysis
May 2009 £180
World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The
May 2009 £2,400
PARP Inhibitors
Competitor Analysis
Apr 2009 £89
Prostate Cancer Therapeutics
Apr 2009 £2,375
Leukemia
A Competitive Analysis to New Products, Portfolio Planning, Licensing & Acquisition Through Pipeline Benchmarking
Apr 2009 £1,780
Hypoxia-Inducible Factor (HIF)
Competitor Analysis
Apr 2009 £89
Multiple Myeloma Therapeutics
Apr 2009 £2,375
Looking at the Cancer Therapy Market
Apr 2009 £420
CD3 Antagonists
Competitor Analysis
Mar 2009 £180
Chinese Markets for Prostate Cancer Treatment Drugs
Feb 2009 £2,405
Chinese Markets for Lung Cancer Treatment Drugs
Feb 2009 £2,405
Chinese Markets for Breast Cancer Treatment Drugs
Feb 2009 £2,405
Cancer Therapies
Feb 2009 £2,375
Global Dialysis Market Report: 2009 Edition
Feb 2009 £515
Prostate Cancer: Drug Pipeline Update 2009
Jan 2009 £1,370
Protein Kinase Inhibitors in Oncology: Drug Pipeline Update 2009
Jan 2009 £1,370
Renal Cancer Drug Pipeline Update 2009
Jan 2009 £1,370
Melanoma Drug Pipeline Update 2009
Jan 2009 £1,370
Apoptosis in Oncology: Drug Pipeline Update 2009
Jan 2009 £1,370
Breast Cancer Drug Pipeline Update 2009
Jan 2009 £1,370
Hematological Cancers Drug Pipeline Update 2009
Jan 2009 £1,825
Ovarian Cancer Drug Pipeline Update 2009
Jan 2009 £1,370
Brain Cancer Drug Pipeline Update 2009
Jan 2009 £1,370
Analytical Tool - Prostate Cancer
A Therapeutic & Competitive Insight
Jan 2009 £2,835
Analytical Tool - Breast Cancer
Jan 2009 £2,835
Stakeholder Opinions: Cancer Cachexia - Higher profile needed to unlock market potential of neglected syndrome
Jan 2009 £2,285
Liver Cancer Drug Pipeline Update 2009
Jan 2009 £915
Antibodies in Oncology: Drug Pipeline Update 2009
Jan 2009 £1,370
Angiogenesis in Oncology: Drug Pipeline Update 2009
Jan 2009 £1,370
Immunotherapy in Oncology: Drug Pipeline Update 2009
Jan 2009 £1,825
Leukemia Drug Pipeline Update 2009
Jan 2009 £1,370
Cancer Market Trends 2008 - 2012
Jan 2009 £1,100
Protein Kinase C (PKC) Inhibitors
Competitor Analysis
Jan 2009 £180
Bladder Cancer Drug Pipeline Update 2009
Jan 2009 £915
Analytical Tool - Melanoma
Jan 2009 £2,835
Analytical Tool - Apoptosis in Oncology
Jan 2009 £2,835
Pancreatic Cancer Drug Pipeline Update 2009
Jan 2009 £1,370
Pipeline Insight: Cancer Overview
Gastrointestinal, Skin, Sarcomas
Jan 2009 £6,950
Lung Cancer Drug Pipeline Update 2009
Jan 2009 £1,370
CD20 Antibodies
Competitor Analysis
Jan 2009 £180
Lymphoma Drug Pipeline Update 2009
Jan 2009 £1,370
Colorectal Cancer Drug Pipeline Update 2009
Jan 2009 £1,370
U.S. Cancer Molecular Diagnostics Markets
Dec 2008 £3,605
China Anti-Cancer Drug Market Report
The Chinese Hospital Cancer Drug Utilization
Dec 2008 £4,950
Pipeline Insight: Molecular Targeted Cancer Therapies
More pipeline activity, less product differentiation
Nov 2008 £8,070
Cancer Vaccines
Market Forecasts, New Developments and Pipeline Analysis
Nov 2008 £2,400
Stakeholder Insight: Chronic Leukemias
Is there room left for improvement?
Nov 2008 £8,070
Global Radiation Therapy Market: 2008 Edition
Nov 2008 £545
Who's Developing What in Drug Delivery?
Oct 2008 £595
European Cancer IVD Market
Oct 2008 £3,910
c-MET/HGF Inhibitors
Competitor Analysis
Oct 2008 £225
Currently Druggable in Prostate Cancer
A Drug Target Competitive Analysis
Sep 2008 £1,780
Cancer Drug Resistance 2008
Sep 2008 £1,675
Global Cancer Treatment Forecast to 2012
Aug 2008 £960
Currently Druggable in Breast Cancer
A Drug Target Competitive Analysis
Aug 2008 £1,780
Cytology and HPV Testing World Markets
Jul 2008 £2,105
Cancer Biomarkers
Adoption Is Driving Growth
Jul 2008 £2,255
Cancer Personalized Medicine 2008
Jul 2008 £2,425
Emerging Trends in Cancer Therapies (Small Molecule Drugs and Biologicals) (Technical Insights)
Jun 2008 £3,910
Integrin Antagonists
Competitor Analysis
Jun 2008 £225
European Lung Cancer Therapeutics Markets
Jun 2008 £3,910
Cancer Antibodies
Competitive Positioning for Success
Jun 2008 £1,780
Cancer Therapeutics Markets
May 2008 £2,075
Cancer Vaccines
Aim and Shoot
May 2008 £1,780
Heat shock protein 90 (Hsp90) Inhibitors
Competitor Analysis
May 2008 £110